<p>I was born in 1991 in Istanbul and completed my medical education at Istanbul University-Cerrahpaşa, Cerrahpaşa Faculty of Medicine, English Program, graduating in 2015. After my internship, I began my residency in otorhinolaryngology at the same faculty, which I completed in 2021. My specialization thesis focused on the tumor immune microenvironment and the expression of regulatory T-cell markers (TIM-3 and LAG-3) in laryngeal cancer.</p> <p>I served as an ENT specialist in Amasya and Tekirdağ, as well as at Marmara University Pendik Training and Research Hospital. I currently work as an Assistant Professor at Istanbul University - Cerrahpaşa, Cerrahpaşa Faculty of Medicine, Department of Otorhinolaryngology. I hold both the Turkish Board of Otorhinolaryngology and Head and Neck Surgery certification (2021) and the European Board of Otorhinolaryngology, Head and Neck Surgery certification (2022).</p> <p>I have contributed to the scientific literature with publications in respected SCI/SCIE-indexed journals. These include original research articles on cochlear implantation, carotid paraganglioma, PFAPA syndrome, olfactory function in COVID-19 patients, and head and neck cancer management during the COVID-19 era, as well as studies derived from my specialty thesis. Beyond publications, I actively serve as a peer reviewer for several international journals. I have presented my work at national and international congresses and contributed as a chapter author to various Turkish otorhinolaryngology textbooks, covering topics from intraoperative cranial nerve monitoring to thyroid and parathyroid diseases.</p> <p>Through diverse clinical, academic, and research activities, I am committed to advancing the field of otorhinolaryngology, with particular interests in oncologic head and neck surgery, surgical education, and innovation.</p>

<p>Graduated in Medicine and Surgery in 2012 at the University of Brescia, BS, Italy.</p> <p>Specialized in Otorhinolaryngology in 2017 under the supervision of Prof. Piero Nicolai, during which I carried out a research project at Mount Sinai Hospital, NY, USA.</p> <p>After completing my residency, I worked at the National Cancer Institute in Milan, MI, Italy under the direction of Prof. Cesare Piazza.</p> <p>I later moved to Trento, where I currently work as the head of the head and neck oncology group under the supervision of Prof. Ottavio Piccin.</p> <p>Author and co-author of publications related to oncology, laryngectomy, and quality of life.</p>

<p>Andrés M. Bur, MD, FACS is the David S. Zamierowski Professor of Otolaryngology – Head and Neck Surgery and Vice Chair of Research at the University of Kansas. He earned his medical degree and completed residency training in Otolaryngology – Head and Neck Surgery at the University of Pennsylvania, followed by fellowship in Head and Neck Surgical Oncology and Microvascular Reconstructive Surgery at Emory University. As a fellowship-trained head and neck oncologic surgeon, his clinical practice focuses on complex oncologic resection and microvascular reconstruction, with particular expertise in transoral robotic surgery and free tissue transfer for advanced head and neck malignancies.</p> <p>Dr. Bur’s research program centers on the development and clinical validation of biologically grounded artificial intelligence platforms for precision head and neck oncology. His work integrates radiomics, spatial transcriptomics, and machine learning to improve treatment response prediction, early cancer detection, and surgical decision-making in HNSCC. Through multi-institutional validation and translational radiogenomic studies linking imaging phenotypes to spatial tumor biology, his research advances a scalable, evidence-based framework for responsible AI implementation in cancer care. Supported by funding from the National Cancer Institute (NCI), National Institute of General Medical Sciences (NIGMS), National Institute on Aging (NIA), and the University of Kansas Cancer Center, Dr. Bur serves as Chair of the Young Members Service and Co-Chair of the Artificial Intelligence Task Force for the American Head and Neck Society. He is an invited national and international speaker on responsible clinical integration of artificial intelligence in otolaryngology and head and neck oncology.</p>